What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences

Background: The potential value of patient preference studies has been recognized in clinical individual treatment decision-making between clinicians and patients, as well as in upstream drug decision-making. Drug developers, regulators, reimbursement and Health Technology Assessment (HTA) bodies ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrocchi, Serena, Janssens, Rosanne, Oliveri, Serena, Arnou, Reinhard, Durosini, Ilaria, Guiddi, Paolo, Louis, Evelyne, Vandevelde, Marie, Nackaerts, Kristiaan, Smith, Meredith Y., Galli, Giulia, de Marinis, Filippo, Gianoncelli, Letizia, Pravettoni, Gabriella, Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970036/
https://www.ncbi.nlm.nih.gov/pubmed/33746750
http://dx.doi.org/10.3389/fphar.2021.602112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970036/
https://www.ncbi.nlm.nih.gov/pubmed/33746750
http://dx.doi.org/10.3389/fphar.2021.602112

Ejemplares similares